Navigation Links
Elsevier to Create New Guidelines for Pharmaceutical Article Reprint, Compilation and Custom Publications
Date:6/4/2009

PHILADELPHIA, Pennsylvania, June 4 /PRNewswire-FirstCall/ --

- Company Also Updates Findings Related to Australian Sponsored Publication Practices From 2000-2005

Elsevier, a leading international publisher of scientific, technical and medical (STM) information products and services, announced today it has moved to provide consistent internal guidelines for its pharmaceutical services divisions when producing reprints, article compilations or custom publications on behalf of pharmaceutical companies. This initiative follows an internal review that was commenced when the company became aware of a series of publications produced in Australia between the years 2000 and 2005 that carried the name "journal of" but lacked proper sponsor disclosures and were not in fact journals and should not have been titled as such.

Given the issues identified in the Australasian series, the company is acting to ensure that all of its pharmaceutical services divisions around the globe are following consistent sponsorship practices and disclosure standards for various article reprint products. While these pharmaceutical services divisions frequently reprint peer reviewed articles from Elsevier, they are managed separately from the division that publishes the company's core collection of primary research journals.

Elsevier will review practices related to all article reprint, compilation or custom publications and set out guidelines on content, permission, use of imprint and repackaging to ensure that such publications are not confused with Elsevier's core peer reviewed journals and that the sponsorship of any publication is clearly disclosed. Elsevier expects to complete its review and issue guidelines by June 30, 2009.

"Full disclosure should be the standard at Elsevier, and we need to strive every day to make sure that we enforce consistent global guidelines for sponsorship and disclos
'/>"/>

SOURCE Elsevier
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine news :

1. Elseviers PharmaPendium(TM) Introduces the FDA Classic Collection
2. Elseviers PharmaPendium introduces the FDA Classic Collection
3. Elsevier Appoints Chris Dillon as Managing Director, Clinical Decision Support
4. Elsevier launches Epidemics -- the journal on infectious disease dynamics
5. Milestone tumor virus publication by Elsevier journal Virology
6. Elsevier Acquires Professional Development Software, Inc., Provider of Software for Nurses Online Learning Education
7. Elsevier and Brain Mapping Foundation co-host 6th Annual World Congress of IBMISPS
8. Three Prize Winners Awarded in Elseviers Article 2.0 Contest
9. Elsevier Partners With Communispace to Launch Global Online Community
10. Elsevier Announces Launch of Osteopathic Family Physician Publishing Partnership Formed With American College of Osteopathic Family Physicians
11. Elsevier Titles Win Four PROSE Awards From Association of American Publishers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2009)..., , "This bill provides for an unprecede...is health care about if it is not for preserving a...ed, it must be defeated." Charmaine Yoest ,,...ericans United for Life Action President and CEO D...the Senate by releasing the following statement: ...
(Date:11/21/2009)..., , LONDON, November 21, 2009 /PRNewswire-...est Test Test Test Test Test Test Test Test Test T...est Test Test Test Test Test Test,Test Test Test T... More test More test More test More test More ...test More test More test More test More test More,...
(Date:11/21/2009)... Eric J. Hall, president an...ation of America (AFA) issued the following statem...t detection as part of the new annual wellness for...ction and Affordable Care Act" that was intro...ork, NY (PRWEB) November 21, 2009 -- Eric J. Hall,...
(Date:11/20/2009)..., , PRINCETON, NJ, Nov. 20 /PRNewswire-First...day that a Special Meeting of Shareholders will be... the Meeting is to consider approval of two specia...approve and authorize the sale of all or substanti...n the terms provided for in the asset purchase agr...
(Date:11/20/2009)... Senators and Congressmen i...ble Over their Health Care Vote , ...-- Senators and congressmen running for re-electio...olitical guru Charlie Cook, may come to regret vot...care bill, according to a breaking Zogby Internati...
Breaking Medicine News(10 mins):Health News:Leading Anti-Abortion Group Vows to Vigorously Fight the Senate Health Bill 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Impairment Detection in Healthcare Reform 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 2Health News:Just 25% of Voters in Competitive 2010 Senate Races “Much More Likely” to Support Pelosi-Democrats Who Voted for Health Care Bill 3
...son Introduces Docuscan Patient History System Wit...logy, BLOOMINGTON, Minn., Sept. 4 Today Pearson ...new innovative solution for,digitally capturing pa...Paros(TM) technology enables,digital capture of pa...
...IGH, N.C., Sept. 4 MedThink Communications, an,in...elations, has been,retained by NanoBio Corporation...zed particles to eradicate skin infections, withou...nd medical,communications in order to advance Nano...
...he next battle in the war on asthma symptom contro... , It turns out that Mom and Dads leeriness towar...king theyre not essential, or believing they pose ...e-breathing disease do not take their prescription...
...he Healthy Steps for Young Children Program, which...ric practices, continued to benefit families more ...ding to a study by researchers from the Johns Hopk...ir childs health care, greater odds that parents w...
...isition of Consultech Strengthens Omnicom,s Presen...althcare Market, BEIJING, Sept. 3 Omnicom Group ... advertising and marketing,services group, has acq...nd marketing communications company based in,China...
... In this weeks press release: , , Renal functio...-induced acute lung injury in mice by mesenchymal ...ease mention PLoS Medicine in your report and use ...ction and coronary heart disease , , John Danesh ...
Other Medicine News:Health News:New 'Smart' Technology Makes Patient Data Collection Easier, More Efficient 2Health News:MedThink Communications Retained by NanoBio Corporation 2Health News:Parents' perceptions can hamper kids' asthma care, study finds 2Health News:Parents' perceptions can hamper kids' asthma care, study finds 3Health News:Practice-based intervention has sustained benefits for children and families 2Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 2Health News:Omnicom Acquires Leading Healthcare Marketing Communications Firm in China 3Health News:Renal function and heart disease, and more 2
(Date:11/20/2009)...wswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin... known as DOR BioPharma, Inc., a late-stage biotec...d a consortium to develop thermostable technology ...ines. Soligenix received a $9.4 million grant from...Diseases (NIAID), a division of the National Insti...
(Date:11/19/2009)...ewswire-FirstCall/ -- BioCryst Pharmaceuticals, In... a public offering of 5,000,000 shares of its comm...oceeds of $48.75 million. All of the shares are b...shelf registration statement previously filed with... has also granted the underwriters a 30-day option...
(Date:11/19/2009)...wswire-FirstCall/ -- In a series of new initiative...oration (Nasdaq: HSKA ) ("Heska" or the "Company"...ed website. The upgraded site is the result of se...o align the site with the company,s new brand imag.../www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO )...
Breaking Medicine Technology:Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 2Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 3Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 4Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 5Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines 6BioCryst Announces Pricing of Public Offering of Common Stock 2BioCryst Announces Pricing of Public Offering of Common Stock 3Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 1Accumetrics VerifyNow 28R 29 P2Y12 Test Provides Physicians With Information to Assess a Patients Response to Newly Approved Prasugrel 28Effient 28R 51616 2Get the Most Out of Your Run 51614 1Get the Most Out of Your Run 51614 2Get the Most Out of Your Run 51614 3Increase in Thyroid Cancer Puzzles Experts 51611 1Increase in Thyroid Cancer Puzzles Experts 51611 2
Liquid Trap
...d Transfer Kit High resolution ,transfer of DNA an...lary transfer allows for,alkaline buffer transfers... hours. , Economical Reusable blotting device re...refill packs available., Compact ,TurboBlotter h...
... using the Antigen-Antibody Pens-Using a proprieta...eveloped specialized fountain pens, called Antigen...deliver or write/mark the blotting membranes in an...tigen-bonded colored dyes helps to see antigen bei...
... using the Antigen-Antibody Pens-Using a proprieta...eveloped specialized fountain pens, called Antigen...deliver or write/mark the blotting membranes in an...tigen-bonded colored dyes helps to see antigen bei...
Medicine Products: